| Code | Description | Claims | Beneficiaries | Total Paid |
| J0178 |
Injection, aflibercept, 1 mg |
1,403 |
715 |
$949K |
| J2777 |
Injection, faricimab-svoa, 0.1 mg |
337 |
199 |
$306K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
3,755 |
3,120 |
$292K |
| J2778 |
Injection, ranibizumab, 0.1 mg |
589 |
356 |
$284K |
| 92134 |
|
6,155 |
5,157 |
$131K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
2,729 |
2,222 |
$106K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
156 |
114 |
$43K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
643 |
581 |
$40K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
251 |
228 |
$21K |
| J9035 |
Injection, bevacizumab, 10 mg |
418 |
230 |
$20K |
| 92136 |
|
153 |
133 |
$5K |
| 99215 |
Prolong outpt/office vis |
41 |
38 |
$4K |
| 92250 |
|
81 |
74 |
$3K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
73 |
57 |
$3K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
25 |
25 |
$2K |
| 76512 |
|
48 |
37 |
$2K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
41 |
35 |
$2K |
| 92133 |
|
60 |
54 |
$1K |
| 92002 |
|
13 |
12 |
$814.32 |
| 92020 |
|
39 |
37 |
$580.56 |
| 92025 |
|
27 |
26 |
$529.85 |